Maia Biotechnology Inc (MAIA)

Currency in USD
1.920
-0.050(-2.54%)
Closed·
1.850-0.070(-3.65%)
·
MAIA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.8802.028
52 wk Range
0.8703.190
Key Statistics
Prev. Close
1.97
Open
2
Day's Range
1.88-2.028
52 wk Range
0.87-3.19
Volume
406.43K
Average Volume (3m)
904.69K
1-Year Change
2.6738%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MAIA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.135
Upside
+532.03%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Maia Biotechnology Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Maia Biotechnology Inc Company Profile

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Compare MAIA to Peers and Sector

Metrics to compare
MAIA
Peers
Sector
Relationship
P/E Ratio
−3.3x−2.4x−0.5x
PEG Ratio
−0.080.050.00
Price/Book
1,763.1x1.9x2.6x
Price / LTM Sales
-9.0x3.3x
Upside (Analyst Target)
-254.5%47.1%
Fair Value Upside
Unlock13.2%5.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 12.135
(+532.03% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 04, 2025
EPS / Forecast
-0.27 / -0.19
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MAIA Income Statement

People Also Watch

1.63
ACRV
+3.16%
4.03
ROLR
+0.75%
3.86
STTK
-1.28%
0.39
RPGL
-4.93%

FAQ

What Is the Maia Biotechnology (MAIA) Stock Price Today?

The Maia Biotechnology stock price today is 1.920

What Stock Exchange Does Maia Biotechnology Trade On?

Maia Biotechnology is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Maia Biotechnology?

The stock symbol for Maia Biotechnology is "MAIA."

What Is the Maia Biotechnology Market Cap?

As of today, Maia Biotechnology market cap is 73.470M.

What Is Maia Biotechnology's Earnings Per Share (TTM)?

The Maia Biotechnology EPS (TTM) is -0.77.

When Is the Next Maia Biotechnology Earnings Date?

Maia Biotechnology will release its next earnings report on Mar 23, 2026.

From a Technical Analysis Perspective, Is MAIA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Maia Biotechnology Stock Split?

Maia Biotechnology has split 0 times.

How Many Employees Does Maia Biotechnology Have?

Maia Biotechnology has 13 employees.

What is the current trading status of Maia Biotechnology (MAIA)?

As of Feb 16, 2026, Maia Biotechnology (MAIA) is trading at a price of 1.920, with a previous close of 1.970. The stock has fluctuated within a day range of 1.880 to 2.028, while its 52-week range spans from 0.870 to 3.190.

What Is Maia Biotechnology (MAIA) Price Target According to Analysts?

The average 12-month price target for Maia Biotechnology is USD12.135, with a high estimate of USD14 and a low estimate of USD10.27. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +532.03% Upside potential.

What Is the MAIA Premarket Price?

MAIA's last pre-market stock price is 2.010. The pre-market share volume is 17,100.000, and the stock has decreased by 0.040, or 2.030%.

What Is the MAIA After Hours Price?

MAIA's last after hours stock price is 1.850, the stock has decreased by -0.070, or -3.650%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.